Transcath closure of vsd
CPT code 93581 covers a minimally invasive heart procedure where a cardiologist uses a catheter to close a hole between the heart's two lower chambers (ventricular septal defect or VSD). This is done through blood vessels without open-heart surgery.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
Billing tips
Bill 93581 as a global procedure code that includes all catheter introduction, imaging guidance, device deployment, and immediate post-procedure assessment. Do not separately bill routine catheter placements or basic fluoroscopy already included.
Impact: Prevents automatic denials from NCCI bundling edits; unbundling can trigger audits and recoupment of $300-$800 in incorrectly billed services
Document complete pre-procedure echocardiographic or angiographic VSD sizing, device selection rationale, and post-deployment imaging confirming position and residual shunt assessment. Include all hemodynamic measurements before and after closure.
Impact: Missing documentation is the #1 cause of claim denials; complete records prevent delays and reduce denial rate from 18% to under 3%
Verify that intracardiac echocardiography (ICE) or transesophageal echocardiography (TEE) used during the procedure is separately billable (93662 or 93315-93318) as it is not bundled with 93581, but requires modifier 59 or XU for distinct procedural service.
Impact: Recovers additional $150-$450 in reimbursement for imaging guidance that many providers fail to bill
When multiple defects are closed during the same session, append modifier 22 with detailed operative note showing additional complexity, time, and device usage. Do not bill 93581 multiple times for the same session.
Impact: Modifier 22 can increase payment by $250-$375 versus incorrect multiple billing which will be denied and may trigger fraud investigation
Confirm pre-authorization is obtained before procedure, as most commercial payers classify VSD closure as a high-cost procedure requiring prior authorization; include defect measurements, symptoms, and medical necessity in submission.
Impact: Failure to obtain pre-auth results in automatic denial of the full $1254.72 Medicare rate (higher for commercial) with patient potentially responsible for payment
Code the appropriate congenital or acquired VSD diagnosis (Q21.0 for congenital muscular, I23.2 for post-MI) as primary diagnosis with specificity; include heart failure or other complications as secondary diagnoses to establish medical necessity.
Impact: Non-specific diagnosis codes trigger medical necessity denials in 12-15% of claims; specific coding supports the 38.79 RVU complexity level
Common denials
Medical necessity not established - payer denies claiming VSD is asymptomatic or too small to warrant intervention
How to appeal: Submit detailed clinical notes documenting symptoms (dyspnea, failure to thrive in pediatrics, reduced exercise tolerance), echocardiographic evidence of significant left-to-right shunt (Qp:Qs ratio >1.5:1), chamber enlargement, or pulmonary hypertension. Include published guidelines from ACC/AHA supporting transcatheter closure criteria.
Bundling denial - payer bundles 93581 with other cardiac catheterization codes (93451-93461) performed same day
How to appeal: Reference CMS NCCI Policy Manual stating 93581 is separately reportable from diagnostic catheterization when anatomically distinct or when diagnostic study leads to decision for immediate intervention. Append modifier 59 if appropriate and document that diagnostic portion was medically necessary and not predetermined.
Insufficient documentation - operative report lacks required elements such as defect location, size measurements, device type/size, deployment confirmation, or residual shunt assessment
How to appeal: Provide complete catheterization report with pre-procedure imaging, hemodynamic data showing shunt quantification, detailed narrative of catheter approach and device deployment steps, fluoroscopic images, and post-deployment assessment. Include physician attestation of medical record completion.
Experimental/investigational denial - payer claims transcatheter VSD closure is not established therapy for certain defect types or patient populations
How to appeal: Submit FDA approval documentation for specific closure device used, peer-reviewed literature supporting safety and efficacy, clinical practice guidelines from American College of Cardiology or American Heart Association, and patient-specific rationale why open surgery poses higher risk. Request peer-to-peer review with payer's medical director.
Frequently asked questions
What is the Medicare reimbursement rate for CPT 93581 in 2025?
The 2025 Medicare national average reimbursement for CPT 93581 is $1254.72 for both facility and non-facility settings. This rate is based on 38.79 total RVUs multiplied by the 2025 conversion factor of 32.3465. Actual payment may vary by geographic locality and payer contract.
Can I bill diagnostic cardiac catheterization codes with CPT 93581 on the same date of service?
Yes, but with restrictions. Diagnostic catheterization codes (93451-93461) may be separately billable if the diagnostic study was medically necessary and not predetermined before the VSD closure decision. Append modifier 59 to the diagnostic code and document clearly that findings during diagnostic catheterization led to the decision for immediate intervention. Many payers will bundle these services if not properly documented.
Is intracardiac echocardiography (ICE) included in CPT 93581 or separately billable?
Intracardiac echocardiography (CPT 93662) is NOT bundled with 93581 and is separately billable. However, you must append modifier 59 or XU to indicate it is a distinct procedural service. TEE (93315-93318) used for guidance is also separately billable with appropriate modifier. This represents additional reimbursement of $150-$450 depending on imaging modality.
What diagnosis codes support medical necessity for transcatheter VSD closure?
Primary diagnosis codes include Q21.0 (ventricular septal defect, congenital), I23.2 (ventricular septal defect as current complication following acute myocardial infarction), or Q21.8 (other congenital malformations of cardiac septa). Supporting secondary diagnoses may include I50.x (heart failure), I27.2 (pulmonary hypertension), or R06.02 (shortness of breath) to establish hemodynamic significance and medical necessity.
How many RVUs is CPT code 93581 worth in 2025?
CPT 93581 has 38.79 total RVUs in 2025, consisting of 24.39 work RVUs, 8.79 practice expense RVUs (both facility and non-facility), and 5.61 malpractice RVUs. This high RVU value reflects the complexity and risk of transcatheter structural heart intervention.
Do I need prior authorization for CPT 93581 procedures?
Most commercial payers and Medicare Advantage plans require prior authorization for CPT 93581 due to the high cost and complexity of transcatheter VSD closure. Submit pre-authorization requests with echocardiographic evidence of defect size, hemodynamic significance (Qp:Qs ratio), symptoms, and rationale for percutaneous versus surgical approach. Failure to obtain authorization typically results in automatic claim denial.
Can CPT 93581 be billed for closure of multiple VSDs during the same procedure?
No, CPT 93581 should only be reported once per session regardless of the number of defects closed. If multiple defects significantly increase procedural complexity, time, and resource utilization, append modifier 22 (increased procedural services) with documentation supporting 20-30% additional reimbursement rather than billing the code multiple times, which will be denied as duplicate billing.